Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/OyaGen> ?p ?o }
Showing triples 1 to 83 of
83
with 100 triples per page.
- OyaGen abstract "OyaGen is a Rochester, New York-based startup company that is focused on developing treatments for HIV. The company was founded in 2003 by Dr. Harold Smith, a professor of biochemistry and biophysics at the University of Rochester. OyaGen was founded on research conducted by Dr. Smith and Dr. Hui Zang, an HIV researcher at Thomas Jefferson University.".
- OyaGen foundationPlace Rochester,_New_York.
- OyaGen foundedBy Harold_Smith_(scientist).
- OyaGen locationCity Rochester,_New_York.
- OyaGen numberOfEmployees "6".
- OyaGen product Lead_compound.
- OyaGen thumbnail OyaGen_logo.jpg?width=300.
- OyaGen type Privately_held_company.
- OyaGen wikiPageExternalLink oyageninc.com.
- OyaGen wikiPageExternalLink www.oyageninc.com.
- OyaGen wikiPageExternalLink animated-feature.
- OyaGen wikiPageExternalLink vif-antagonist.
- OyaGen wikiPageExternalLink science.
- OyaGen wikiPageExternalLink 81.
- OyaGen wikiPageExternalLink S0968000410002239.
- OyaGen wikiPageID "42927298".
- OyaGen wikiPageLength "8016".
- OyaGen wikiPageOutDegree "32".
- OyaGen wikiPageRevisionID "641857409".
- OyaGen wikiPageWikiLink APOBEC3G.
- OyaGen wikiPageWikiLink Agonist.
- OyaGen wikiPageWikiLink Agonists.
- OyaGen wikiPageWikiLink Assay.
- OyaGen wikiPageWikiLink Biotechnology.
- OyaGen wikiPageWikiLink Category:Companies_based_in_Rochester,_New_York.
- OyaGen wikiPageWikiLink AIDS_research_institutes.
- OyaGen wikiPageWikiLink Chief_executive_officer.
- OyaGen wikiPageWikiLink Chief_operating_officer.
- OyaGen wikiPageWikiLink Chief_science_officer.
- OyaGen wikiPageWikiLink HIV.
- OyaGen wikiPageWikiLink Harold_Smith_(scientist).
- OyaGen wikiPageWikiLink Lead_compound.
- OyaGen wikiPageWikiLink Lead_compounds.
- OyaGen wikiPageWikiLink National_Institutes_of_Health.
- OyaGen wikiPageWikiLink Pharmaceutical_sciences.
- OyaGen wikiPageWikiLink Privately_held_company.
- OyaGen wikiPageWikiLink Protein_dimer.
- OyaGen wikiPageWikiLink RNA.
- OyaGen wikiPageWikiLink RNA_editing.
- OyaGen wikiPageWikiLink Rochester,_New_York.
- OyaGen wikiPageWikiLink Seed_funding.
- OyaGen wikiPageWikiLink Seed_money.
- OyaGen wikiPageWikiLink Startup_company.
- OyaGen wikiPageWikiLink Thomas_Jefferson_University.
- OyaGen wikiPageWikiLink University_of_Rochester.
- OyaGen wikiPageWikiLink Viral_infectivity_factor.
- OyaGen wikiPageWikiLinkText "OyaGen".
- OyaGen areaServed "Global".
- OyaGen foundation "Rochester, New York 2003".
- OyaGen founder "Dr. Harold Smith".
- OyaGen hasPhotoCollection OyaGen.
- OyaGen homepage oyageninc.com.
- OyaGen locationCity Rochester,_New_York.
- OyaGen locationCountry "US".
- OyaGen logo "OyaGen logo.jpg".
- OyaGen logoCaption "Therapeutics Targeting Editing Enzymes".
- OyaGen name "OyaGen, Inc.".
- OyaGen numEmployees "6".
- OyaGen products "Antiviral therapeutic lead compounds".
- OyaGen type Privately_held_company.
- OyaGen wikiPageUsesTemplate Template:Infobox_company.
- OyaGen wikiPageUsesTemplate Template:Reflist.
- OyaGen subject Category:Companies_based_in_Rochester,_New_York.
- OyaGen subject AIDS_research_institutes.
- OyaGen hypernym Rochester.
- OyaGen type Agent.
- OyaGen type Company.
- OyaGen type Organisation.
- OyaGen type Organization.
- OyaGen type Agent.
- OyaGen type SocialPerson.
- OyaGen type Thing.
- OyaGen type Q43229.
- OyaGen comment "OyaGen is a Rochester, New York-based startup company that is focused on developing treatments for HIV. The company was founded in 2003 by Dr. Harold Smith, a professor of biochemistry and biophysics at the University of Rochester. OyaGen was founded on research conducted by Dr. Smith and Dr. Hui Zang, an HIV researcher at Thomas Jefferson University.".
- OyaGen label "OyaGen".
- OyaGen sameAs m.010s6z0w.
- OyaGen sameAs Q17092286.
- OyaGen sameAs Q17092286.
- OyaGen wasDerivedFrom OyaGen?oldid=641857409.
- OyaGen depiction OyaGen_logo.jpg.
- OyaGen homepage oyageninc.com.
- OyaGen isPrimaryTopicOf OyaGen.
- OyaGen name "OyaGen, Inc.".